Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01216605Phase 4Completed
A Phase 4 trial of oxytocin in Autism Spectrum Disorder (ASD), sponsored by University Hospital Freiburg. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01216605.